MedPath
HSA Approval

FLUMAZENIL KABI SOLUTION FOR INJECTION OR INFUSION 0.1MG/ML

SIN15610P

FLUMAZENIL KABI SOLUTION FOR INJECTION OR INFUSION 0.1MG/ML

FLUMAZENIL KABI SOLUTION FOR INJECTION OR INFUSION 0.1MG/ML

January 9, 2019

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

V03AB25

flumazenil

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Fresenius Kabi Austria GmbH

Active Ingredients

FLUMAZENIL

0.1mg/ml

Flumazenil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FLUMAZENIL KABI SOLUTION FOR INJECTION OR INFUSION 0.1MG/ML - HSA Approval | MedPath